Skip to content

Clinical Trial Evaluating Gunjasuranadi Suppository for Internal Haemorrhoids (Abhyantara Arshas).

A Randomized Controlled Clinical Study To Evaluate The Efficacy Of Gunjasuranadi Suppository Over Corect Suppository In The Management Of Abhyantara Arshas (1st&2nddegree Internal Haemorrhoids). - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103352
Enrollment
40
Registered
2026-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K641- Second degree hemorrhoids

Interventions

None listed

Sponsors

Dr Sreenivas Gorantla
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects aged 21-65 years, irrespective of gender diagnosed with first or second-degree internal haemorrhoids, having haemoglobin levels greater than 8 gm/dl and presenting with maximum three pile masses will be selected.

Exclusion criteria

Exclusion criteria: Internal Haemorrhoids with associated Ano rectal diseases like Fistula in Ano, Fissure in Ano, Perianal Abscess, Gluteal Abscess and CA Rectum. Pregnant women and Lactating mothers. Known case of any Tuberculosis. Patients with HIV, Hepatitis B or C and systemic disorders such as Chron s disease, Ulcerative colitis, Hypertension, Coronary artery diseases Portal Hypertension and Diabetes Mellitus. Patients diagnosed with any malignancy condition.

Design outcomes

Primary

MeasureTime frame
Regression of Pile mass with minimum pain and discomfort and minimal expected bleeding.Timepoint: 7 Days

Secondary

MeasureTime frame
NILTimepoint: Nil

Countries

India

Contacts

Public ContactDr Lohit Kalal

Shri Jagadguru Gavisiddheshwara Ayurvedic Medical College,Koppal

dr.lohitkalal7108@gmail.com7090116108

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026